Prednisone and Aspirin
ApprovedSmall molecule
Prednisone and Aspirin is one of 8 small molecule programs targeting Autoimmunity. It is currently in Approved.
1
Indications
2
Total Trials
1
Active Trials
7
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
10 competitors in Autoimmunity
#DrugCompanyPhaseTrials
1Skyrizi
AbbVieApproved
Trexall
Alnylam PharmaceuticalsPhase 3
Biological Collection
AAssistance Publique - Hôpitaux de Paris
Approved
Ocrevus
RochePhase 2
Proleukin
IIovance Biotherapeutics, Inc.
Phase 2
Prednisone and Aspirin
SSecond Affiliated Hospital, School of Medicine, Zhejiang University
Approved
BRIUMVI
TTG Therapeutics, Inc.
Phase 2
TOL-3021
TTolerion, Inc.
Phase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Autoimmunity2 trials
An Assessment of Aspirin Plus Prednisone Treatment for Euthyroid Women With Thyroid Autoimmunity
Unknown status·SSecond Affiliated Hospital, School of Medicine, Zhejiang University··NCT04943146·402 enrolled
Effect of Prednisone and Aspirin on IVF-ET Outcome Among Patients With Thyroid Autoimmunity
Not yet recruiting·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·Phase 4·NCT05578456·540 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Prednisone and Aspirin. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details